MB
JUNS

MidFirst Bank’s Jupiter Neurosciences JUNS Stock Holding History

MidFirst Bank’s Portfolio JUNS Stock Details JUNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$214 Hold
13
– – ﹤0.01% 901
2026
Q1 		$376 Hold
13
– – ﹤0.01% 846
2025
Q4 		$1.02K Buy
+13
New +$1.3K ﹤0.01% 709

Other funds holding JUNS

VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
LFAS
Level Four Advisory Services Dallas, Texas $3.54B AUM 37.12% 1-Year Est. Return
VC
Vestor Capital Chicago, Illinois $1.59M AUM 51.04% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

MidFirst Bank's JUNS Position: Q2 2026 in Review

MidFirst Bank held its Jupiter Neurosciences (JUNS) position steady in Q2 2026 at 13 shares worth $214. The position accounts for ﹤0.01% of the portfolio, ranked #901.

MidFirst Bank first reported a position in JUNS in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.02K in Q4 2025. 11 funds tracked by Wall St. Rank hold JUNS as of Q2 2026.

  • MidFirst Bank held 13 shares of Jupiter Neurosciences worth $214 as of Q2 2026.
  • MidFirst Bank left its Jupiter Neurosciences share count unchanged in Q2 2026.
  • Jupiter Neurosciences made up ﹤0.01% of MidFirst Bank's portfolio in Q2 2026, its #901 holding.
  • MidFirst Bank first reported a position in Jupiter Neurosciences in Q4 2025 and has held it in 3 quarters since.
  • MidFirst Bank's Jupiter Neurosciences position peaked at $1.02K in Q4 2025.
  • 11 funds tracked by Wall St. Rank held Jupiter Neurosciences as of Q2 2026.

Based on MidFirst Bank's 13F filing for Q2 2026, filed 7 Aug 2026.